Skip to main content
OpenTrials
Completed

NCT Number: NCT01159951

Analysis of Trends Over Time of Hepatitis Related Incidence in Panama

The purpose of this study is to analyze the incidence of baseline hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) together with the current frequency of the same outcome after introduction of Havrix™ in Panama.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis Digestive System Diseases Liver Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

GSK Investigational Site

Clayton, Provincia de Panamá, Panama

About this study

In this study, systematic review of the databases of epidemiologic surveillance system (Ministry of Health), for hepatitis related outcomes will be performed. The analysis will be performed by age group, years and country region.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hepatitis related outcomes occurred during the period analyzed and registered in the Epidemiologic Surveillance System of the Ministry of Health, will be collected for the study

Exclusion criteria

  • Not applicable

Treatment and study plan

Epidemiologic Surveillance System of the Ministry of Health of Panama

Other

Systematic review of the databases of epidemiologic surveillance system, Ministry of health, Panama

Primary outcomes

  1. Occurrence of reported hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis)

    Time frame: In post vaccine introduction period (2008-2010) compared to pre-vaccination period (2000-2007)

Secondary outcomes

  1. Occurrence of hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) by year

    Time frame: From year 2000 until year 2010

  2. Occurrence of hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) by age groups

    Time frame: From year 2000 until year 2010

  3. Occurrence of hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) by region

    Time frame: From year 2000 until year 2010

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

Time Trend Analysis of the Incidence of Hepatitis- Related Outcomes (Viral Hepatitis A and Unspecified Viral Hepatitis) Reported to the Surveillance System of Panama, 2000-2010

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jul 12, 2010
Registry last updated
Jun 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.